Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

Experimental drug slashes triglycerides and remnant cholesterol in trial, potentially filling gap for patients with ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, remnant cholesterol and fat in models and a Phase 1 trial without harming ...

A selective Liver X Receptor inverse agonist lowered triglycerides and post-meal cholesterol in people, opening a safer path to treat hypertriglyceridemia.

Asharq Al Awsat A study led by researchers from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, revealed ...